Stocks-ALM.MC-Laboratorios Almirall SA

ALM.MC Laboratorios Almirall SA

8.565 0.045 (0.53%)
Trade
Trade

Overview

Prev Close 8.565
Day's Range 8.337 - 8.602
52 Week Range 7.753 - 10.055
Average Volume (3M) 113.37K
1-Year Return -13.62%
Beta-0.0191
Market Cap 1.82B
P/E Ratio-50.72
Revenue925.67M
EPS-0.1678
Dividend (Yield) 0.14904 (1.74%)
Industry
Pharmaceuticals Major
CEO
Carlos Gallardo Piqué, MBA
Employees
1,904

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Laboratorios Almirall SA's revenues increased by 4.12% and amounted to 898.80M. Net income decreased by NaN to -38.50M. Net assets decreased by NaN to N/A and EPS decreased from N/A to -0.18.
ALM.MC's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
39.18%
Net Profit Margin
2.57%
Operating Margin
4.19%
Return On Investment
1.29%
06/15
09/15
12/15
03/16
Total Revenue
179.4M
161.4M
164.2M
184.9M
Gross Profit
122.1M
112.4M
109.8M
130.3M
Operating Income
20.1M
6.8M
4.9M
16.3M
Net Income
15.9M
14.5M
58.5M
21.7M